Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07650448 · ClinicalTrials.gov registry record · NA
WATER IV PCa (AS Sub-study)
A NA study, sponsored by PROCEPT BioRobotics.
- Not yet
- Registry status
- NA
- Development phase
- 333
- Enrollment target
NCT07650448 is a NA study that has not yet begun recruiting, run by PROCEPT BioRobotics. The registered enrollment target is 333 participants.
The verdict
NCT07650448, a NA study, has not yet begun recruiting, sponsored by PROCEPT BioRobotics.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 333 participants
- Enrollment target
Study Summary
The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.
Interventions
- OTHER Active Surveillance
- DEVICE Aquablation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2026-09 |
| Est. Completion | 2038-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07650448
The ClinicalTrials.gov registry entry for NCT07650448 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PROCEPT BioRobotics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Surveillance is the first listed.
NCT07650448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07650448 about?
NCT07650448 is a clinical study titled "WATER IV PCa (AS Sub-study)". The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.
What is the current status of trial NCT07650448?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 333 participants. The study started on 2026-09. Estimated completion is 2038-12.
What interventions are being tested in trial NCT07650448?
The interventions under investigation include: Active Surveillance (OTHER), Aquablation Therapy (DEVICE).
Who is sponsoring clinical trial NCT07650448?
This trial is sponsored by PROCEPT BioRobotics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.